MedPath

rinary Tract Infection -An oral administration of siddha classical drug Kollukkaivelai ver kudineer

Phase 2
Conditions
Health Condition 1: N390- Urinary tract infection, site notspecified
Registration Number
CTRI/2023/10/058379
Lead Sponsor
Government Siddha Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with symptoms of

1.Dysuria

2.Frequency

3.Urgency

4.Pain over suprapubic region

5.Hematuria

6.Recurrent UTI

Exclusion Criteria

1.Pregnancy

2.Lactating women

3.Chronic Kidney Disease

4.Autoimmune conditions like Glomerular nephritis

5.Renal calculi

6.Hydronephrosis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome will be reduction of less than 1,00,000 CFU/ml in urine culture and reduction of the following symptoms <br/ ><br>1. Dysuria <br/ ><br>2. Frequency <br/ ><br>3. Urgency <br/ ><br>4. Suprapubic pain <br/ ><br>5. HematuriaTimepoint: 10 days
Secondary Outcome Measures
NameTimeMethod
The secondary outcome will be the observation of siddha diagnostic parameters.Timepoint: 10 days
© Copyright 2025. All Rights Reserved by MedPath